The independent intelligence layer for the peptide space.
Provider directory, price intelligence, and graded research — ranked by data, never by revenue.
Switch compound
Price intelligence · BPC-157
$0.30 vs last week$5.97/mg median
59 vendors tracked · research use only
- Providers verified
- 81%
- Countries covered
- 7
- Compounds tracked
- 117
- Providers tracked
- 2,745
- 2,228 verified
- Vendor prices tracked
- 827
- research vendors, $/mg
- Price index refresh
- Weekly
- median $/mg
Every provider is scored the same way.
Rankings come from one documented 100-point rubric — shown in full below. Beside it: the six-dimension trust framework, a separate read on provider conduct from public signals. Read the methodology →
Scoring rubric
v4 · 100 pts totalVerification status
Licensed provider, compliance type, sourcing documentation
Rating & review data
Independent review count and rating source quality
Telehealth coverage
Remote consultation availability and geographic reach
Peptide breadth
Depth and diversity of compound catalog
Commercial relationships
Revenue has never influenced a score. Ever.
What we watch beyond the rankings. Flip a card to see what it measures.
New dimension signals are added as they are verified.
Commercial relationships — 0 pts
Zero dollars taken from providers, vendors, or affiliates. Ever.
- No vendor money
- No affiliate links
- No paid placements
PeptideBase has no commercial relationship with any provider or vendor it ranks. Read the full methodology →
Independent research, delivered weekly — price movements, new verifications, evidence tier changes.
One email a week. No spam.
Price intelligence
Know what peptides actually cost.
Median $/mg with the vendor range for every tracked compound — captured fresh each week. Research use only.
- Compounds priced
- 39
- Vendor prices tracked
- 827
- Providers tracked
- 2,745
Prices captured Jul 27
Weekly cadence · next capture in ~6d
One email when a compound's median $/mg moves — nothing else. It only fires on a price change.
Median $/mg · captured weekly · high-confidence research vendor data only · not clinical pricing · verify directly with vendors
Start from an outcome, not a compound.
Each goal maps to the peptides researchers study for it and the providers who carry them.
Weight loss & metabolic
01AOD-9604 · Tesamorelin · CJC-1295 (without DAC)
Better skin
02GHK-Cu · Cartalax · SNAP-8
Injury & recovery
03BPC-157 · TB-500 · DSIP
Athletic performance
04Ipamorelin · Sermorelin · GHRP-6
Sleep & stress
05BPC-157 · TB-500 · DSIP
Longevity & aging
06MOTS-c · Epithalon · NAD+
Cognitive & focus
07Selank · Semax · Pinealon
Hair growth
08GHK-Cu · Cartalax · SNAP-8
Work the literature, not the marketing.
Every compound graded by research maturity — four tiers reflect how much published literature exists, not whether a compound works.
32
Early
limited published research
76
Emerging
growing research base
7
Moderate
multiple study types
1
Established
extensive literature
Most compounds sit in the early tiers — that skew is honest, and it's exactly why we grade them.
Research stacks
Combinations indexed from published literature — not protocols or treatment plans.
Compare compounds
Mechanism, half-life, risk profile, and providers — side by side.
Four ways to find what you need.
Jump straight to the surface you need — every one is built from the same independently maintained data.
Provider directory
Filter 2,700+ providers by state, provider type, telehealth availability, verification, and compounds carried.
Open the directory →
Price intelligencePeptide price index
Compare median $/mg across research vendors before you buy — refreshed every week.
See the index →
Research libraryCompound research
Look up any compound’s mechanism, evidence tier, and regulatory status. Educational only.
Browse compounds →
ToolsResearch stacks & calculators
Explore goal-grouped research stacks, compare compounds side by side, and run the reconstitution calculator.
Open the tools →
Analysis, not content.
Written from the dataset and reviewed for accuracy. Educational context only — never medical advice.
Peptide Therapy Near Me: How to Find a Verified Local Provider
Find peptide therapy near you: 2,200+ verified US providers across 52 states, including telehealth platforms for states with limited local access.
Jun 8, 2026 · 9 min
AnalysisPeptides for Weight Loss: GLP-1 Agonists, Growth Hormone Fragments, and What the Research Shows
GLP-1 agonists, GH-releasing peptides, and growth hormone fragments studied for fat loss — research summaries and verified US providers.
Jun 8, 2026 · 13 min
AnalysisHow PeptideBase Verifies Providers
The PeptideBase directory lists 3,136 active providers. Here's exactly what we check — and what we don't — before we assign a verified badge.
May 3, 2026 · 6 min
Quarterly reportState of Peptide Therapy — Q2 2026
Market structure, pricing trends, and regulatory movement across the provider landscape — from the full dataset.
Read the report →
Listed on PeptideBase?
Claim your profile to correct or update your listing.
Before you browse.
Six questions we get every week. Short answers — longer explanations live in the methodology page.
Still unsure? Read the full methodology →
No. PeptideBase is an educational directory and matching tool. We aggregate publicly available information about providers and compounds. Nothing on the platform is a prescription, treatment plan, or substitute for consultation with a licensed clinician.
Smart sort weights four objective signals: verification status (35%), rating & review data (25%), telehealth coverage (20%), and peptide breadth (20%). You can re-sort by any single criterion at any time.
No. Provider rankings are determined by a documented algorithmic scoring system — verification status, review data, telehealth availability, and peptide breadth. No provider can pay to influence their ranking.
Clinics employ licensed practitioners who can prescribe. Compounding pharmacies (503A / 503B) formulate and dispense against a prescription. Vendors sell compounds for research use only — no prescription, no medical guidance, and not for human consumption.
A small number — Semaglutide and Tirzepatide among them — are FDA-approved for specific indications. Most peptides catalogued on PeptideBase are not FDA-approved and are dispensed under compounding exemptions or sold for research. Each peptide page lists its current regulatory status.
The 7-question quiz runs entirely client-side. No account is required to receive a match. We log aggregate, anonymized response distributions to improve the matching model — never tied to an identity. You can review the data we collect on our privacy page.
The commitments
Why trust PeptideBase
- Independent verification
- Providers are assessed against a published 4-criteria rubric. Verification status is earned, not purchased.
- Ranked by data, not revenue
- Smart sort orders by verification, review data, and peptide breadth. No revenue relationship has ever influenced a provider's position.
- No sponsored placements
- There are no paid slots, boosted listings, or featured-provider fees. Every ranking is algorithmic.
- Educational only
- PeptideBase provides research context, not medical advice. We don't provide personal dosing or treatment recommendations.
Start with the data.
Educational use only · No medical advice · No signup required